Successful treatment of chromoblastomycosis with itraconazole.
An unusual severe case of chromoblastomycosis due to Cladosporium carrionii unresponsive to 5-FC and some azoles is reported. With oral itraconazole at a dosage of 100 mg d(-1) for 15 months (total dose 45.5 g) the patient had a complete clinical and mycological recovery without any side-effects.
Yu
R
R
Department of Dermatology, General Hospital of PLA, Beijing, China.
D002862:Chromoblastomycosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D017964:Itraconazole